Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 3
Submit an article Journal homepage
2,497
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study

Asmik Asatryana Hospital Stomamedservice, Gatchina, Russian FederationView further author information
,
Nadia Meyerb GSK, Wavre, BelgiumView further author information
,
Michael Scherbakovc GSK, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0002-9189-4729View further author information
ORCID Icon,
Victor Romanenkod Children’s City Hospital No11, Ekaterinburg, Russian FederationView further author information
,
Irina Osipovae Ooo “Asko-med-plus”, Barnaul, Russian FederationView further author information
,
Anna Galustyanf Medical Technologies Ltd, St. Petersburg, Russian Federation;g Federal State Budgetary Educational Institution of Higher Education, St. Petersburg State Pediatric Medical University of the Ministry of Healthcare of the Russian Federation, St. Petersburg, Russian FederationView further author information
,
Olga Shamshevah Pirogov Russian National Research Medical University, Moscow, Russian FederationView further author information
,
Tatiana Latyshevai NRC Institute of Immunology FMBA, Moscow, RussiaView further author information
,
Tatyana Myasnikovai NRC Institute of Immunology FMBA, Moscow, RussiaView further author information
,
Nathalie Baudsonj GSK Vaccines, Rixensart, BelgiumView further author information
,
Monique Dodetj GSK Vaccines, Rixensart, BelgiumView further author information
,
Stebin Xavierb GSK, Wavre, BelgiumView further author information
,
Lauriane Harringtonb GSK, Wavre, BelgiumView further author information
,
Anastasia Kuznetsovab GSK, Wavre, BelgiumView further author information
,
Laura Camporab GSK, Wavre, BelgiumView further author information
&
Peter Van den Steenb GSK, Wavre, BelgiumCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7931-1781View further author information
ORCID Icon show all
Pages 723-730 | Received 16 Mar 2020, Accepted 12 Jul 2020, Published online: 26 Aug 2020

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.